Vor Biopharma VOR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $169.87M-57.2% | $396.49M+147% | $160.46M-15.8% | $190.57M+281% | $50.05M-38.9% | ||
| $321.65M+448% | $58.72M+487% | $10M+0.1% | $9.99M0.0% | $9.99M+0.1% | ||
| $500.78M+9.3% | $458.11M+166% | $172.49M-15.8% | $204.93M+216% | $64.85M-32.8% | ||
| $565K+6.0% | $533K+96.7% | $271K— | $0-100% | $5.99M-9.0% | ||
| $506.75M+9.2% | $464.13M+163% | $176.24M-14.2% | $205.37M+87.9% | $109.31M-23.5% | ||
| $1.04M-79.7% | $5.13M+479% | $885K+32.3% | $669K-82.1% | $3.73M+148% | ||
| $16.08M-36.1% | $25.17M+33.6% | $18.84M-67.9% | $58.77M+251% | $16.73M-10.1% | ||
| $657.17M+4.6% | $628.44M-73.8% | $2.4B+40.4% | $1.71B+3,857% | $43.24M-6.5% | ||
| $19K+5.6% | $18K+20.0% | $15K+15.4% | $13K0.0% | $13K0.0% | ||
| -$1.37B-19.0% | -$1.15B+59.9% | -$2.88B-39.4% | -$2.06B-321% | -$489.48M-7.1% | ||
| -$150.42M+8.5% | -$164.31M+92.6% | -$2.23B-47.8% | -$1.51B-2,379% | $66.07M+168% | ||
| $506.75M+9.2% | $464.13M+163% | $176.24M-14.2% | $205.37M+87.9% | $109.31M-23.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vor Biopharma's total assets?
- Vor Biopharma (VOR) holds $506.7M in total assets, up 363.6% year over year.
- How much debt does Vor Biopharma have?
- Vor Biopharma carries $2.9M in total debt against -$150.4M of shareholders' equity, a debt-to-equity ratio of 0.47.
- How much cash does Vor Biopharma have?
- Vor Biopharma holds $169.9M in cash and equivalents.
- Can Vor Biopharma cover its short-term obligations?
- Its current ratio is 31.15 — current assets exceed current liabilities.
- Where does Vor Biopharma's balance sheet data come from?
- Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.